Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content

Table 6 Organ at risk dosimetry of patients with grade 3 or higher toxicity

From: Ten fraction hypofractionated stereotactic body radiotherapy for the management of ultracentral lung tumors: a retrospective analysis of dosimetry, outcomes, and toxicity

 

Prior irradiation

MLD (Gy)

TL V40 (%)

ESO Dmax (Gy)

ESO V40 (cc)

BT Dmax (Gy)

BT V50 (cc)

GV Dmax (Gy)

GV V50 (cc)

Reference constraint [10, 23]

Toxicity

Pneumonitis

         

MLD ≤ 9 Gy

 Patient 1

60 Gy/30fx

12.6

2

      

TL V40 ≤ 7%

 Patient 2

70.2 Gy/39fx

6.3

2.2

       

 Patient 3

–

10.5

3.4

       

Esophagitis

         

ESO Dmax ≤ 50 Gy

 Patient 2

70.2 Gy/39fx

  

57.8

6.33

    

ESO V40 ≤ 1 cc

Airway toxicity

         

BT Dmax ≤ 60 Gy

 Patient 4

     

73.6

7.7

  

BT V50 ≤ 1 cc

 Patient 5

     

79.1

4.2

   

Hemorrhage

         

BT Dmax ≤ 60 Gy

 Patient 6

70 Gy/35fx

    

72.6

4.9

72.9

5.42

BT V50 ≤ 1 cc

 Patient 7

50 Gy/5fx

    

77.4

5.7

73.7

16.8

GV Dmax ≤ 75 Gy

 Patient 8

–

    

75

1.94

57.3

3.2

GV V50 ≤ 1 cc

  1. Vx: volume (percentage or cubic centimeters) of tissue exposed to x Gy or more, Dmax: maximum dose, MLD: mean lung dose, TV: total lung, ESO: esophagus, BT: bronchial tree, GV: great vessel, fx: treatment fractions, Gy: Gray
Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us